Mary Mosher

Array ( [id] => 7018835 [patent_doc_number] => 20050220854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Apparatus and method for transdermal delivery of influenza vaccine' [patent_app_type] => utility [patent_app_number] => 11/084631 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 16420 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220854.pdf [firstpage_image] =>[orig_patent_app_number] => 11084631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 575685 [patent_doc_number] => 07456009 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-25 [patent_title] => 'Adenovirus formulations' [patent_app_type] => utility [patent_app_number] => 11/071095 [patent_app_country] => US [patent_app_date] => 2005-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 18059 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/456/07456009.pdf [firstpage_image] =>[orig_patent_app_number] => 11071095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 570444 [patent_doc_number] => 07459163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Infectious DNA as a vaccine against west nile and other flaviviruses' [patent_app_type] => utility [patent_app_number] => 11/065783 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 11280 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459163.pdf [firstpage_image] =>[orig_patent_app_number] => 11065783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236535 [patent_doc_number] => 20070128692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Chimeric empty capsids of the infectious bursal disease viruse (ibdv), obtainment process and applications' [patent_app_type] => utility [patent_app_number] => 10/579428 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13184 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128692.pdf [firstpage_image] =>[orig_patent_app_number] => 10579428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391215 [patent_doc_number] => 20090208528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Empty capsids (vlps(-vp4)) of the infectious bursal disease virus (ibdv), obtainment process and applications' [patent_app_type] => utility [patent_app_number] => 10/576988 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10138 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208528.pdf [firstpage_image] =>[orig_patent_app_number] => 10576988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 864114 [patent_doc_number] => 07368232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'High-throughput assay for virus entry and drug screening' [patent_app_type] => utility [patent_app_number] => 11/036568 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 13327 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368232.pdf [firstpage_image] =>[orig_patent_app_number] => 11036568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7069432 [patent_doc_number] => 20050244817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Mammalian genes involved in viral infection and tumor suppression' [patent_app_type] => utility [patent_app_number] => 11/033764 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16308 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20050244817.pdf [firstpage_image] =>[orig_patent_app_number] => 11033764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4971209 [patent_doc_number] => 20070111211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Integrated viral complexes, methods of production thereof, vaccines containing same and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/585058 [patent_app_country] => US [patent_app_date] => 2004-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7373 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111211.pdf [firstpage_image] =>[orig_patent_app_number] => 10585058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5827785 [patent_doc_number] => 20060063148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Porcine reproductive and respiratory syndrome isolates and methods of use' [patent_app_type] => utility [patent_app_number] => 11/022262 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9827 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063148.pdf [firstpage_image] =>[orig_patent_app_number] => 11022262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 602168 [patent_doc_number] => 07431929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Use of vaccinia virus deleted for the E3L gene as a vaccine vector' [patent_app_type] => utility [patent_app_number] => 11/022477 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13365 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/431/07431929.pdf [firstpage_image] =>[orig_patent_app_number] => 11022477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793145 [patent_doc_number] => 20060013826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Recombinant measles viruses expressing epitopes of antigens of RNA viruses - use for the preparation of vaccine compositions' [patent_app_type] => utility [patent_app_number] => 11/014842 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 23330 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013826.pdf [firstpage_image] =>[orig_patent_app_number] => 11014842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095107 [patent_doc_number] => 20070116716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Sars coronavirus s proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/582301 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12466 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116716.pdf [firstpage_image] =>[orig_patent_app_number] => 10582301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211206 [patent_doc_number] => 07622112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Anti-SARS monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 10/581613 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11370 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622112.pdf [firstpage_image] =>[orig_patent_app_number] => 10581613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252800 [patent_doc_number] => 20070134256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Monoclonal antibodies that bind or neutralize dengue virus' [patent_app_type] => utility [patent_app_number] => 10/582006 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 39395 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134256.pdf [firstpage_image] =>[orig_patent_app_number] => 10582006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7074299 [patent_doc_number] => 20050147567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Compositions comprising an active agent' [patent_app_type] => utility [patent_app_number] => 10/985509 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14727 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147567.pdf [firstpage_image] =>[orig_patent_app_number] => 10985509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135975 [patent_doc_number] => 20050180994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Methods and compositions for the identification of anti-poxvirus agents' [patent_app_type] => utility [patent_app_number] => 10/975285 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25672 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180994.pdf [firstpage_image] =>[orig_patent_app_number] => 10975285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322301 [patent_doc_number] => 07517531 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4' [patent_app_type] => utility [patent_app_number] => 10/970640 [patent_app_country] => US [patent_app_date] => 2004-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 30904 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517531.pdf [firstpage_image] =>[orig_patent_app_number] => 10970640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161583 [patent_doc_number] => 20050084936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Human regulatory proteins' [patent_app_type] => utility [patent_app_number] => 10/965898 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37865 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084936.pdf [firstpage_image] =>[orig_patent_app_number] => 10965898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135973 [patent_doc_number] => 20050180992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Viral fibers' [patent_app_type] => utility [patent_app_number] => 10/965665 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9342 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180992.pdf [firstpage_image] =>[orig_patent_app_number] => 10965665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084959 [patent_doc_number] => 20070275010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Mva Vaccines' [patent_app_type] => utility [patent_app_number] => 10/572229 [patent_app_country] => US [patent_app_date] => 2004-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 16143 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275010.pdf [firstpage_image] =>[orig_patent_app_number] => 10572229 [rel_patent_id] =>[rel_patent_doc_number] =>)